Diagnosis |
47 |
9.1% |
RDT |
25 |
4.9% |
Parasitologically-confirmed diagnosis |
9 |
1.7% |
Diagnostics comparison |
10 |
1.9% |
Perception & adherence to guidelines |
2 |
0.4% |
QA/EQA |
1 |
0.2% |
Treatment |
84 |
16.3% |
G6PD |
3 |
0.6% |
Anti-relapse and Primaquine |
6 |
1.2% |
Accessibility to treatment |
10 |
1.9% |
Adherence to treatment |
15 |
2.9% |
Home management |
18 |
3.5% |
Efficacy and resistance to antimalarial |
5 |
1.0% |
Treatment perception & behaviour |
27 |
5.2% |
Prevention |
52 |
10.1% |
Community perception & practice |
14 |
2.7% |
Prevention & IPTp |
27 |
5.2% |
Prevention & IPTi |
5 |
1.0% |
Prevention & IPTc |
5 |
1.0% |
Chemoprophylaxis |
1 |
0.2% |
Vector control |
129 |
25.0% |
Perception & acceptability of IRS |
5 |
1.0% |
Perception & acceptability of bednets |
32 |
6.2% |
Environment management |
5 |
1.0% |
Mosquito sampling methods |
5 |
1.0% |
ITN vs IRS and combination |
5 |
1.0% |
Ownership & utilization of bednets |
40 |
7.8% |
Bionomics of vector & efficacy of insecticide |
21 |
4.1% |
Larvae & larviciding |
4 |
0.8% |
Impact of anti-vector intervention |
5 |
1.0% |
Outdoor-biting |
4 |
0.8% |
Sustain or phase out of vector intervention |
1 |
0.2% |
IVM |
1 |
0.2% |
Geographical Reconnaissance (GR) |
1 |
0.2% |
Epidemiology & transmission |
85 |
16.5% |
Infection reservoir-asymptomatic, submicroscopic, gametocyte carriers |
15 |
2.9% |
Risk factor & Prevalence |
22 |
4.3% |
Hotspot & foci |
7 |
1.4% |
Importation |
13 |
2.5% |
Elimination strategy |
2 |
0.4% |
Reintroduction |
4 |
0.8% |
Risk & distribution mapping/model |
22 |
4.3% |
Surveillance |
19 |
3.8% |
Reporting & quality of data |
6 |
1.2% |
Mobile phone-based case detection |
3 |
0.6% |
ACD vs PCD |
8 |
1.6% |
Surveillance as intervention |
1 |
0.2% |
Early warning & response |
1 |
0.2% |
Health system |
73 |
14.2% |
Health worker's perception & practice |
27 |
5.2% |
Availability & use of service |
7 |
1.4% |
Health facility performance |
19 |
3.7% |
Provision of service by private sectors |
6 |
1.2% |
Perception & adherence to guidelines of private sectors |
5 |
1.0% |
Subsidy policy to private sectors |
8 |
1.6% |
Malaria reporting by private sectors |
1 |
0.2% |
Cost-effectiveness |
26 |
5.0% |
|
26 |
5.0% |
Total
|
515 |
100.0%
|
|
515
|
100.0% |